Chordia Therapeutics

company

About

Chordia Therapeutics is a research and development type bioventure specializing in oncology field.

  • 11 - 50

Details

Last Funding Type
Series A
Last Funding Money Raised
¥1.20B
Industries
Health Diagnostics,Medical
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Chordia Therapeutics is a research and development type bioventure specializing in oncology field. The company has a mission of delivering new therapeutic drugs to patients as soon as possible in the area of ​​cancer with high unmet medical need.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥1.20B
Chordia Therapeutics has raised a total of ¥1.20B in funding over 2 rounds. Their latest funding was raised on Nov 23, 2017 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 23, 2017 Series A ¥1.20B 1 Takeda Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Chordia Therapeutics is funded by 1 investors. Takeda are the most recent investors.
Investor Name Lead Investor Funding Round
Takeda Yes Series A